In conjunction with Pharmaceutical Commerce, Acsis recently surveyed manufacturers to capture serialization progress, challenges and expected benefits of going “beyond” Drug Supply Chain Security Act (DSCSA) compliance.
In this paper, you’ll read about the survey results and learn:
- Where companies are on the DSCSA compliance timeline and which processes will be affected when
- Technical challenges and business expectations for the compliant warehouse
- How best-in-class companies are approaching serialization
- Considerations of addressing immediate and longer-term compliance milestones
- How to plan your next steps on the journey to compliance and serialization payback